Showing results (241-250 of 245) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
Journal of Cancer Research and Clinical Oncology|December 12, 2022
Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world studyMara Persano, Margherita Rimini, Toshifumi Tada, et al.Liver International : Official Journal of the International Association for the Study of the Liver|March 22, 2024
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumabMargherita Rimini, Bernardo Stefanini, Toshifumi Tada, et al.Targeted Oncology|April 30, 2024
Adverse Events as Potential Predictive Factors of Activity in Patients with Advanced HCC Treated with Atezolizumab Plus BevacizumabMara Persano, Margherita Rimini, Toshifumi Tada, et al.Targeted Oncology|January 22, 2024
Safety and Efficacy of Lenvatinib in Very Old Patients with Unresectable Hepatocellular CarcinomaSilvia Camera, Margherita Rimini, Federico Rossari, et al.European Journal of Cancer (Oxford, England : 1990)|December 17, 2022
Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide populationAndrea Casadei-Gardini, Margherita Rimini, Toshifumi Tada, et al.Pageof 25